Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
New breast cancer study findings reported from University of California
April 3rd, 2008
"In mice bearing human breast cancer xenografts, we examined the biodistribution of F-18-fluorocyclophosphamide (F-18-F-CP) to evaluate its potential as a noninvasive prognostic tool for predicting the resistance of tumors to cyclophosphamide therapy. F-18-F-CP was synthesized as we recently described, and PET data were acquired after administration of F-18-F-CP in mice bearing human breast cancer xenografts (MCF-7 cells)," researchers in the United States report. "Tracer biodistribution in reconstructed images was quantified by region-of-interest analysis. Distribution was also assessed by harvesting dissected organs, tumors, and blood, determining F-18 content in each...
Source: Women's Health Weekly (2008-04-03)
|
